N1033787
Figure 8- Shapiro-Wilk test of normality for Recumbency
Figure 9- Kruskal-Wallis test for Temperature Decreases and Recumbency
4.4 Body temperature decreases and premedication The SPSS system was unable to analyse and determine the distribution of some of the groups within the premedication variable, as the n number was considered too low. This was applicable for the following groups:
• Opioid & Midazolam( n = 1, body temperature decrease of 0.5 ° C)
• Opioid, Alpha-2 agonists & Midazolam( n = 2, mean = 2.4, SD = 0.424)
• Alpha-2 agonists alone( n = 1, body temperature decrease of 0.1 ° C)
• Opioid & Lidocaine( n = 1, body temperature decrease of 2 ° C)
• Lidocaine alone( n = 1, body temperature decrease of 0.2 ° C)
• Opioid, Alpha-2 agonists & Ketamine( n = 1, no change in body temperature). For the reason, the above groups were omitted, and their data excluded from this part of the study. The remaining groups, opioid & alpha-2 agonists( n = 62, mean = 1.36, SD = 0.8), opioid & ACP( n = 10, mean = 1.51, SD = 0.752), opioid alone( n = 12, mean = 1.14, SD = 0.656) and opioid, alpha-2 agonists and ACP( n = 8, mean = 1.6, SD = 0.69), all provided data that was
ANIM32126 – EBVN Project 23